Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AMGN - Amgen wins approval of first biosimilar of AstraZeneca's Soliris

AMGN - Amgen wins approval of first biosimilar of AstraZeneca's Soliris

May, 29 2024 01:01 PM Amgen Inc.

2024-05-29 13:01:37 ET

More on Amgen, AstraZeneca

Amgen Stock: Poised To Break Out (Technical Analysis)
AstraZeneca, Amgen release mid-stage data on Tezspire for COPD
Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo
Amgen, Inc. (AMGN) ATS and the Approval of IMDELLTRA Conference - (Transcript)
Amgen Inc. (AMGN) BofA Securities 2024 Health Care Conference (Transcript)

For further details see:

Amgen wins approval of first biosimilar of AstraZeneca's Soliris

Stock Information

Company Name:	Amgen Inc.
Stock Symbol:	AMGN
Market:	NASDAQ
Website:	amgen.com

AMGN AMGN Quote AMGN Short AMGN News AMGN Articles AMGN Message Board

Get AMGN Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.